Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01528982 · ClinicalTrials.gov registry record · NA
Susceptibility to Pathological Gambling
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 588
- Enrollment target
NCT01528982: Completed NA study, sponsored by University of Chicago.
NCT01528982 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 588 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01528982, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 588 participants
- Enrollment target
Study Summary
The goal of this study is to assess the risk factors for the development of pathological gambling.
Primary Outcome
The SCI-PG is a validated and reliable scale assessing the presence of DSM-IV criteria for pathological gambling. The number of criteria met for PG is added for a total score and those meeting 5 or more criteria have DSM-IV pathological gambling. Subjects are expected to be followed for the duration of the 3 year study. Diagnostic criteria for pathological gambling every 3 months for the length of the study
Interventions
- BEHAVIORAL Cognition
- BEHAVIORAL Mindfulness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 588 participants |
| Start Date | 2008-11 |
| Est. Completion | 2024-06 |
| Phase | NA |
What the finished NCT01528982 record still lists
NCT01528982 is an interventional study that assigns participants to a tested intervention. The registered 588 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognition is the first listed.
NCT01528982 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01528982 about?
NCT01528982 is a clinical study titled "Susceptibility to Pathological Gambling". The goal of this study is to assess the risk factors for the development of pathological gambling.
What is the current status of trial NCT01528982?
This trial is currently completed. It is a NA study. The enrollment target is 588 participants. The study started on 2008-11. Estimated completion is 2024-06.
What interventions are being tested in trial NCT01528982?
The interventions under investigation include: Cognition (BEHAVIORAL), Mindfulness (BEHAVIORAL).
Who is sponsoring clinical trial NCT01528982?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01528982's enrollment target sits among peer trials
588 176th of 2000 higher than 1,825 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06921603 · 588 participants · NA
POCUS-Guided Diuresis for Decompensated Heart Failure
- NCT06986954 · 588 participants
Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study
- NCT01365169 · 590 participants · NA
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
- NCT03774758 · 590 participants
Biomarkers for Risk Stratification in Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia